← FDA Drug Approvals (Drugs@FDA)
SIROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-03-12
Drug application
- FDA Application #
ANDA214753- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SIROLIMUS
- Generic name
- SIROLIMUS
- Active ingredients
- SIROLIMUS
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- Manufacturer
- Ascend Laboratories, LLC
- First approval
- 2021-03-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown